J L Valentine

753 total citations
26 papers, 560 citations indexed

About

J L Valentine is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, J L Valentine has authored 26 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Surgery. Recurrent topics in J L Valentine's work include Nausea and vomiting management (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Retinal Development and Disorders (4 papers). J L Valentine is often cited by papers focused on Nausea and vomiting management (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Retinal Development and Disorders (4 papers). J L Valentine collaborates with scholars based in United States, Brazil and United Kingdom. J L Valentine's co-authors include S. Michael Owens, L W Arnold, John J. Weiter, Donald A. Frambach, William D. Wessinger, Michael Mayersohn, Larry Arnold, Mark E. Arnold, Deborah Panebianco and Arlene Taylor and has published in prestigious journals such as Analytical Chemistry, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J L Valentine

25 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J L Valentine United States	15	237	147	98	65	62	26	560
Shunji Yamazaki Japan	12	272 1.1×	131 0.9×	65 0.7×	21 0.3×	32 0.5×	20	681
Peter Neubert United States	11	184 0.8×	43 0.3×	41 0.4×	29 0.4×	85 1.4×	24	736
Yuji Ohno Japan	14	205 0.9×	118 0.8×	93 0.9×	18 0.3×	140 2.3×	37	737
W. McNally United States	12	104 0.4×	54 0.4×	82 0.8×	80 1.2×	14 0.2×	16	438
Meizi Liu United States	11	180 0.8×	77 0.5×	38 0.4×	31 0.5×	77 1.2×	22	758
T. Hesselbo United Kingdom	5	180 0.8×	100 0.7×	107 1.1×	16 0.2×	145 2.3×	9	584
Mariagnes Verosky United States	15	334 1.4×	151 1.0×	76 0.8×	27 0.4×	18 0.3×	51	777
Naoki Matsumoto Japan	19	268 1.1×	45 0.3×	122 1.2×	26 0.4×	94 1.5×	70	984
Rowland H. Han United States	13	351 1.5×	87 0.6×	100 1.0×	47 0.7×	56 0.9×	25	734
Ruth Ann Subach United States	10	490 2.1×	413 2.8×	122 1.2×	24 0.4×	17 0.3×	20	768

Countries citing papers authored by J L Valentine

Since Specialization

Citations

This map shows the geographic impact of J L Valentine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J L Valentine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J L Valentine more than expected).

Fields of papers citing papers by J L Valentine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J L Valentine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J L Valentine. The network helps show where J L Valentine may publish in the future.

Co-authorship network of co-authors of J L Valentine

This figure shows the co-authorship network connecting the top 25 collaborators of J L Valentine. A scholar is included among the top collaborators of J L Valentine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J L Valentine. J L Valentine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

LaFranco-Scheuch, Lisa, Vasudevan Bakthavatchalu, Julie T. Ziegler, et al.. (2023). Effects of LRRK2 Inhibitors in Nonhuman Primates. Toxicologic Pathology. 51(5). 232–245. 4 indexed citations

Ashikaga, T., K Wilson, Claire F. Verschraegen, et al.. (2016). Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim. Supportive Care in Cancer. 24(7). 3085–3093. 23 indexed citations

Yuan, Long, Hao Jiang, Naiyu Zheng, et al.. (2014). A validated LC–MS/MS method for the simultaneous determination of BMS-791325, a hepatitis C virus NS5B RNA polymerase inhibitor, and its metabolite in plasma. Journal of Chromatography B. 973. 1–8. 19 indexed citations

Marbury, Thomas, Bo Jin, Deborah Panebianco, et al.. (2011). Pharmacokinetics of Oral Dexamethasone and Midazolam When Administered With Single-Dose Intravenous 150 mg Fosaprepitant in Healthy Adult Subjects. The Journal of Clinical Pharmacology. 51(12). 1712–1720. 27 indexed citations

Liu, Guowen, J L Valentine, Greg Cosma, et al.. (2010). Evaluating and Defining Sample Preparation Procedures for DBS LC–MS/MS Assays. Bioanalysis. 2(8). 1405–1414. 30 indexed citations

Stoch, S. Aubrey, Cynthia Gargano, J L Valentine, et al.. (2010). Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant. Cancer Chemotherapy and Pharmacology. 67(6). 1313–1321. 13 indexed citations

Brainard, Diana M., David H. Wright, Peng Sun, et al.. (2009). 937 SAFETY, TOLERABILITY, AND PHARMACOKINETICS AFTER SINGLE AND MULTIPLE DOSES OF MK-3281 IN HEALTHY SUBJECTS. Journal of Hepatology. 50. S341–S341. 7 indexed citations

Murphy, M. Gail, Bo Jin, Deborah Panebianco, et al.. (2009). Effect of Aprepitant 40 mg on Cyto - chrome P-450 2C9 Activity: A Random- ized, Double-Blind, Placebo-Controlled, Parallel-Group Study in Healthy Young Adults. 2 indexed citations

Gore, Lia, Sant P. Chawla, Antônio Sérgio Petrilli, et al.. (2008). Aprepitant in adolescent patients for prevention of chemotherapy‐induced nausea and vomiting: A randomized, double‐blind, placebo‐controlled study of efficacy and tolerability. Pediatric Blood & Cancer. 52(2). 242–247. 66 indexed citations

10.

Garner, C. Edwin, Susan Sumner, Jason P. Burgess, et al.. (2006). Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration. Toxicology and Applied Pharmacology. 215(1). 23–36. 32 indexed citations

11.

Scalzo, Frank M., et al.. (1998). Gestational exposure to cocaine or pharmacologically related compounds: Effects on behavior and striatal dopamine receptors. Life Sciences. 63(22). 2015–2022. 18 indexed citations

12.

Valentine, J L & S. Michael Owens. (1996). Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.. Journal of Pharmacology and Experimental Therapeutics. 278(2). 717–724. 63 indexed citations

13.

Valentine, J L, Michael Mayersohn, William D. Wessinger, L W Arnold, & S. Michael Owens. (1996). Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.. Journal of Pharmacology and Experimental Therapeutics. 278(2). 709–716. 45 indexed citations

14.

Valentine, J L, L W Arnold, & S. Michael Owens. (1994). Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats.. Journal of Pharmacology and Experimental Therapeutics. 269(3). 1079–1085. 40 indexed citations

15.

Owens, S. Michael, Melinda G. Gunnell, Elizabeth M. Laurenzana, & J L Valentine. (1993). Dose- and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1261–1266. 13 indexed citations

16.

Valentine, J L, et al.. (1993). Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats.. Journal of Pharmacology and Experimental Therapeutics. 266(3). 1439–1445. 32 indexed citations

17.

Rhee, H. M., et al.. (1990). Toxic effects of cocaine to the cardiovascular system in conscious and anesthetized rats and rabbits: evidence for a direct effect on the myocardium.. PubMed. 11(2). 361–6. 9 indexed citations

18.

Frambach, Donald A., J L Valentine, & John J. Weiter. (1989). Topical phenylephrine for mydriasis affects rabbit retinal pigment epithelial transport.. PubMed. 30(2). 343–4. 3 indexed citations

19.

Frambach, Donald A., J L Valentine, & John J. Weiter. (1989). Furosemide-sensitive Cl transport in bovine retinal pigment epithelium.. PubMed. 30(10). 2271–4. 10 indexed citations

20.

Frambach, Donald A., J L Valentine, & John J. Weiter. (1988). Alpha-1 adrenergic receptors on rabbit retinal pigment epithelium.. PubMed. 29(5). 737–41. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact